# TBI/Flu/Bu/Mel Combined With Secondary UCBT in Patients With Hematological Malignancies Who Relapsed After Allo-HSCT

> **NCT06125483** · NA · RECRUITING · sponsor: **The First Affiliated Hospital of Soochow University** · enrollment: 38 (estimated)

## Conditions studied

- Hematopoietic Malignancy
- Relapse/Recurrence
- Hematopoietic Stem Cell Transplantation

## Interventions

- **PROCEDURE:** Umbilical Cord Blood Transplantation

## Key facts

- **NCT ID:** NCT06125483
- **Lead sponsor:** The First Affiliated Hospital of Soochow University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-11-01
- **Primary completion:** 2025-04-30
- **Final completion:** 2026-10-31
- **Target enrollment:** 38 (ESTIMATED)
- **Last updated:** 2025-04-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06125483

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06125483, "TBI/Flu/Bu/Mel Combined With Secondary UCBT in Patients With Hematological Malignancies Who Relapsed After Allo-HSCT". Retrieved via AI Analytics 2026-07-25 from https://api.ai-analytics.org/clinical/NCT06125483. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*